Oxamflatin : A novel compound which reverses malignant phenotype to normal one via induction of JunD

Oncogene

Volumn 13, Issue 1, 1996, Pages 143-149

  Sonoda, Hikaru ^a   Nishida, Kazuyo ^a   Yoshioka, Takayuki ^a   Ohtani, Mitsuaki ^a   Sugita, Kenji ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Fibronectin; Inhibitor; junD; ras; Transformation

Indexed keywords

FIBRONECTIN; HYDROXAMIC ACID DERIVATIVE; SULFONAMIDE;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN 3T3; GENE REPRESSION; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C JUN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; ENZYME ACTIVATION; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HYDROXAMIC ACIDS; MAP KINASE KINASE KINASE 1; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; ONCOGENE PROTEIN P21(RAS); ONCOGENE PROTEINS V-RAF; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; RETROVIRIDAE PROTEINS, ONCOGENIC; TUMOR STEM CELL ASSAY;

EID: 0029946960     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Angel P and Karin M. (1991). Biochim. Biophys. Acta., 1972, 129-157.
2. Bos JL. (1989). Cancer Res., 49, 4682-4689.
3. Casini A. et al. (1994). Alcohol and Alcoholism, 29, 303-314.
4. Chen JY et al. (1995). EMBO J., 14, 1187-1197.
5. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
6. Church GM and Gilbert W. (1984). Proc. Natl. Acad. Sci. USA, 81, 1991-1995.
7. Cox AD et al. (1994). J. Biol. Chem., 269, 19203-19206.
8. Cutler ML, Bassin RH, Zanoni L and Talbot N. (1992). Mol. Cell. Biol., 12, 3750-3756.
9. Dérijard B et al. (1994). Cell, 76, 1025-1037.
10. Fujita T et al. (1986). Cell, 46, 401-407.
11. Fatumura M et al. (1995). Oncogene, 10, 1119-1123.
12. Graham F and Van der Eb AJ. (1973). Virol., 52, 456-467.
13. Hynes RO. (ed.) (1990). Fibronectins (Springer-Verlag, New York), chap.12.
14. James GL et al. (1993). Science, 260, 1937-1942.
15. Kameda T. et al. (1993). Proc. Natl. Acad. Sci. USA, 90, 9369-9373.
16. Kim J-H et al (1994). J. Biol. Chem., 269, 13740-13743.
17. Kitayama H et al. (1989). Cell, 56, 77-84.
18. Kohl NE et al. (1993). Science, 260, 1934-1937.
19. Kreisberg JI et al. (1994). Kidney International, 46, 105-112.
20. Kuo M-L and Yang N-C. (1995). Biochem. Biophys. Res. Commun., 212, 767-775.
21. Marshall CJ. (1994). Curr. Opin. Genet. Dev., 4, 82-89.
22. McCormick F. (1994). Curr. Opin. Genet. Dev., 4, 71-76.
23. Murray MJ et al. (1981). Cell, 25, 355-361.
24. Nakajima T et al. (1992). Mol. Cell. Biol., 12, 2837-2846.
25. Noda M, Selinger Z., Scolnick EM and Bassin RH. (1983). Proc. Natl. Acad. Sci. USA, 80, 5602-5606.
26. Ohtani M et al. (1993). International patent. WO93/12075.
27. Pfarr CM et al. (1994). Cell, 76, 747-760.
28. Prasad GL, Fuldner RA and Cooper HL. (1993). Proc. Nutl. Acad. Sci. USA, 90, 7039-7043.
29. Schreiber E, Matthias P, Müller MM and Schaffner W. (1989). Nuc. Acid. Res., 17, 6419.
30. Srebrow A et al. (1993). FEBS lett., 327, 25-28.
31. Sugita K, Yoshida H, Matsumoto M and Matsutani S. (1992a). Biochem. Biophvs. Res. Commun., 182, 379-387.
32. Sukita K, Koizumi K and Yoshida H. (1992b). Cancer Res., 52, 168-172.
33. Vogelstein B and Kinzler KW. (1993). Trends Genet., 9, 138-141.
34. Yoshida H and Sugita K. (1992). Jpn. J. Cancer Res., 83, 324-328.
35. Zhao J-F, Nakano H and Sharma S. (1995). Oncogene, 11, 161-173.